duroquinone has been researched along with dicumarol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, J; Asher, G; Dym, O; Shaul, Y; Tsvetkov, P | 1 |
| Baumgardt, S; Bongard, RD; Gonzalez, FJ; Hoffmann, R; Lindemer, BJ; Merker, MP | 1 |
2 other study(ies) available for duroquinone and dicumarol
| Article | Year |
|---|---|
The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol.
Topics: Animals; Apoproteins; Benzoquinones; Catalytic Domain; Crystallization; Crystallography, X-Ray; Dicumarol; Enzyme Inhibitors; Humans; Indolequinones; Models, Molecular; NAD(P)H Dehydrogenase (Quinone); Phenylalanine; Protein Binding; Protein Conformation; Rats; Triazines; Tyrosine | 2006 |
Genetic evidence for NAD(P)H:quinone oxidoreductase 1-catalyzed quinone reduction on passage through the mouse pulmonary circulation.
Topics: Animals; Benzoquinones; Dicumarol; Lung; Mice; NAD(P)H Dehydrogenase (Quinone); Oxidation-Reduction; Pulmonary Circulation; Ubiquinone | 2011 |